Online citations, reference lists, and bibliographies.
← Back to Search

Bioavailability And Efficacy Characteristics Of Two Different Oral Liquid Formulations Of Albendazole.

J. García, F. Bolás, J. Torrado
Published 2003 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The oral bioavailability and anthelmintic efficacy in mice of a new formulation of albendazole (ABZ) dissolved in a solution of hydroxypropyl-beta-cyclodextrin (HPCD) are compared with a conventional ABZ suspension of carboxymethylcellulose. Plasma concentrations of ABZ and albendazole sulphoxide (ABZ-SO), its active and main metabolite, were assayed by HPLC. The AUC(0- infinity ) and C(max) values obtained for both ABZ and ABZ-SO, after administration of the ABZ-HPCD solution were significantly higher (P<0.01) than those obtained from the ABZ suspension. Although, the differences between the ABZ and ABZ-SO-T(max) values were found not to be significant, regardless of the formulation. The anthelmintic activities against enteral (pre-adult) and parenteral (migrating and encysted larvae) stages of Trichinella spiralis were studied in mice. The ABZ solution was more efficient against pre-adult and encysted larvae than the ABZ suspension. The efficacy differences between both formulations against the migrating larvae, were found to be not significant (P<0.05). For the migrating parasite stage, there was a linear correlation between the anthelmintic activity and pharmacokinetical parameters with respect to the ABZ-AUC(0- infinity ) value. Meanwhile, for the muscular encysted parasite stage, better relationships were obtained for AUC(0- infinity ) and C(max) values from ABZ-SO, which had correlation coefficients of 0.996 and 0.987, respectively.
This paper references
10.1081/DDC-100102294
Preparation and Characterization of Albendazole β-Cyclodextrin Complexes
J. A. Castillo (1999)
10.2307/3283538
Allozyme analysis of Trichinella isolates from various host species and geographical regions.
G. La Rosa (1992)
10.1016/S0378-5173(97)00204-4
A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation
S. Torrado (1997)
Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats.
E. Benoit (1992)
10.1016/S0020-7519(97)00052-0
Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice.
M. López-García (1997)
10.1017/S0022149X00022021
Studies with methyridine and Trichinella spiralis. 2. The use of the drug to study the rate of larval production in mice.
D. Denham (1970)
10.1159/000239602
Improvement of albendazole efficacy against enteral, but not against parenteral stages of Trichinella spiralis by preparing solid dispersions in polyvinylpyrrolidone.
M. López (1997)
10.1016/0378-5173(96)04545-0
Formulation parameters of albendazole solution
S. Torrado (1996)
10.1111/j.2042-7158.1998.tb03303.x
Biopharmaceutics: Absorption Studies of Albendazole and Some Physicochemical Properties of the Drug and Its Metabolite Albendazole Sulphoxide
H. Jung (1998)
10.1016/0378-5173(96)04586-3
Preparation, dissolution and characterization of albendazole solid dispersions
S. Torrado (1996)
10.1111/J.1365-2885.1990.TB00790.X
Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep.
P. Delatour (1990)
Development of a parenteral and of an oral formulation of albendazole with cyclodextrins
G. Piel (1999)
10.1002/CHIR.530020306
Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats.
P. Delatour (1990)
10.1016/0034-5288(91)90095-6
Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle.
P. Delatour (1991)
10.1016/S0304-4017(97)00177-5
Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime.
M. López-García (1998)
10.1016/S0378-4347(98)00497-6
Quantitative determination of albendazole and its main metabolites in plasma.
J. García (1999)
10.1051/PARASITE/200108S2188
Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes.
J. A. García-Rodriguez (2001)
10.3109/00498259109039463
Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.
P. Delatour (1991)
10.1007/978-94-011-4681-4_52
Influence of Cyclodextrins on the Solubility and the Pharmacokinetics of Albendazole
B. Evrard (1999)
10.1002/(SICI)1099-081X(199801)19:1<65::AID-BDD76>3.0.CO;2-8
Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats
P. Redondo (1998)



This paper is referenced by
10.1093/JAC/DKL329
2-Hydroxypropyl-beta-cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model.
A. Casulli (2006)
10.1016/j.exppara.2013.07.017
In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst.
S. Ahmadnia (2013)
Improvement of Albendazole Solubility and Dissolution Rate by Ternary Solid Dispersion Technique
Samar Elsamaligy (2014)
10.1017/S0031182020001225
Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice.
G. Vural (2020)
INVEstIGatION OF tHE bINarY sYstEMs OF aLbENDaZOLE WItH HYDrOXYPrOPYL-bEta- cYcLODEXtrIN
C. Trandafirescu (2007)
10.3760/cma.j.issn.0366-6999.2011.18.002
Hydatid cyst/cystic echinococcosis: anatomical and surgical nomenclature and method to quantify the cyst content solidification
Menezes A. da Silva (2011)
ALBENDAZOLE AND ITS ANALOGUES
J. E. Harti (2014)
10.1016/J.JPBA.2004.02.022
Simultaneous determination of albendazole and its major active metabolite in human plasma using a sensitive and specific liquid chromatographic-tandem mass spectrometric method.
X. Chen (2004)
10.1007/S10847-005-6287-Y
Factors Contributing to Solubility Synergism of Some Basic Drugs with β-Cyclodextrin in Ternary Molecular Complexes
M. Omari (2006)
10.1371/journal.pntd.0002838
Exploring the Potential of Flubendazole in Filariasis Control: Evaluation of the Systemic Exposure for Different Pharmaceutical Preparations
L. Ceballos (2014)
Efficacy of albendazole against experimental infections of coenurus cerebralis in goats. Humoral and molecular characterization of coenurus cerebralis
de Santana Afonso (2016)
10.1007/S10953-008-9277-Z
Astemizole/Cyclodextrin Inclusion Complexes: Phase Solubility, Physicochemical Characterization and Molecular Modeling Studies
Mahmoud M. Al Omari (2008)
10.3109/03639045.2016.1151036
Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying
Alejandro J. Paredes (2016)
Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
A. Ehteda (2012)
10.1016/J.IJPHARM.2007.05.013
Biopharmaceutic evaluation of novel anthelmintic (1H-benzimidazol-5(6)-yl)carboxamide derivatives.
J. Rivera (2007)
10.1016/j.ijpharm.2010.10.002
Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity.
J. García-Rodríguez (2011)
10.1155/2010/583297
Human Echinococcosis: A Neglected Disease
António Fernandes Menezes da Silva (2010)
10.1016/j.tvjl.2008.11.010
Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications.
B. P. Capece (2009)
10.1111/j.2042-7158.2011.01279.x
Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes
T. Loftsson (2011)
10.1016/j.phrs.2018.04.025
Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis
N. S. Lam (2018)
10.1016/j.ijpddr.2015.09.001
Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule
L. Ceballos (2015)
10.1016/J.IJPHARM.2003.11.030
The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
K. Daniel-Mwambete (2004)
10.1159/000342924
Nematodicidal Activity of Flubendazole and Its Reduced Metabolite on a Murine Model of Trichinella spiralis Infection
L. Urbizu (2012)
10.1111/j.2042-7158.2010.01149.x
Development and oral bioavailability assessment of a supersaturated self‐microemulsifying drug delivery system (SMEDDS) of albendazole
T. Mukherjee (2010)
Solubility of a compound with fasciolicidal activity: evaluation of efficacy in vitro and experimentally on infected sheep with Fasciola hepatica
Javier Arturo Munguía Xóchihua (2010)
10.2478/v10007-012-0031-0
Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure.
A. K. Meena (2012)
10.1007/s00436-008-0980-x
Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations
L. Ceballos (2008)
Préparation permettant un transport amélioré d'agents chimiques
Zimei Wu (2005)
10.1016/j.vetpar.2014.01.027
Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis.
P. Pensel (2014)
10.1016/J.EJPS.2007.09.009
Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis.
A. Avdeef (2008)
10.1155/2010/583297
Human Echinococcosis: A Neglected Disease
A. M. da Silva (2010)
10.2147/DDDT.S65561
Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose
P. M. de la Torre-Iglesias (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar